Navigation Links
The Scleroderma Foundation Applauds Introduction of First Bill in the Senate Promoting Research and Awareness of Scleroderma

DANVERS, Mass., Aug. 4 /PRNewswire-USNewswire/ -- The Scleroderma Foundation applauds Senator Kirsten Gillibrand (D-NY) for introducing S. 1545, the "Scleroderma Research and Awareness Act" in the United States Senate. This important legislation, co-sponsored by Senator Charles Schumer (D-NY), gives hope to the estimated 300,000 Americans and their families living with this devastating disease.

Scleroderma is a chronic and disabling connective tissue disorder resulting from an overproduction of collagen. The word "scleroderma" means hardening of the skin, which is one of the most visible manifestations of the disease. Scleroderma can affect many areas of the body including the heart, lungs, kidneys, and gastrointestinal system. There is no known cause and no cure. The disease disproportionately impacts women and minorities. African Americans are at a higher risk of developing systemic scleroderma, and women account for 80% of all diagnoses. The estimated total economic impact of scleroderma in the United States is $1.5 billion annually. The direct cost of treatment for patients is more than $460 million annually.

The "Scleroderma Research and Awareness Act" would:

  • Direct the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health to expand research related to scleroderma. The legislation authorizes $25 million in FY10, $30 million in FY11, and $35 million in FY12 for this purpose. Priority areas include:
    • Development and evaluation of new treatments.
    • Research on the relationship between scleroderma and secondary conditions including: pulmonary hypertension, gastroparesis, Raynaud's phenomenon, and Sjogren's syndrome.
    • Establishment of family and "childhood-onset" patient registries.
    • Support for the training of new investigators.
  • Direct the Centers for Disease Control and Prevention to establish a scleroderma public awareness campaign highlighting disease symptoms, prevalence, related conditions, and the importance of early diagnosis. The legislation authorizes $2.5 million in FY10, FY11, and FY12 for the awareness initiative.

"The Scleroderma Foundation is proud to be at the forefront of advocating for greater research for this devastating disease," commented Joseph P. Camerino, Ph.D., Chair of the Foundation's National Board of Directors. "With the introduction of this landmark legislation, the scleroderma community has renewed hope that a cure will be found. We are extremely grateful to Senator Gillibrand and Senator Schumer for their leadership on our behalf. We are also grateful for the efforts of many volunteers who comprise the Foundation's Advocacy Committee who have dedicated a great deal of time and energy to champion these efforts."

The Foundation encourages all patients, family members, and friends to contact their representatives in Congress and ask them to co-sponsor this important bill. For more information, please visit

Headquartered in Danvers, Mass., the Scleroderma Foundation is the nation's largest patient organization dedicated to improving the quality of life for patients with scleroderma; the Foundation is also the largest nonprofit provider of funds supporting peer-reviewed scleroderma research in the United States.

    Media Contacts:

    Robert Riggs,
    Chief Development Officer
    Scleroderma Foundation
    800-722-4673, ext. 11


    Brian Ross Adams
    Executive Director
    Scleroderma Foundation, Southern California Chapter

SOURCE Scleroderma Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo.
2. The Scleroderma Foundation Applauds Introduction of First Bill In Congress Promoting Research and Awareness of Scleroderma
3. New Source of Information on Scleroderma Medications
4. Tissue-Growth Gene Tied to Scleroderma
5. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
6. Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts
7. President Obama Presented With Startling Book The Art of Conscious Parenting by the American Foundation for Conscious Parenting
8. Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy
9. Foundation Radiology Group Signs Exclusive Contract With Pennsylvanias Wayne Memorial Hospital
10. Eleven Veterinary Students Win Top Awards at Morris Animal Foundations Annual Research Competition
11. NephCure Foundation Announces Research Grant Program Recipients
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... ... recently awarded their highest five-star rating to Best Buy Eyeglasses, an ... United States and Canada wear eyeglasses. Once considered to be a purely functional part ... fashion statement. Even celebrities use glasses as a way of creating an iconic image—like ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology: